The TSX Venture Exchange has accepted for filing documentation relating to a share purchase agreement dated Dec. 22, 2025, between LSL Pharma Group Inc. and an arm's-length party. Pursuant to the agreement, the company has acquired all of the outstanding shares of Juno OTC Inc., a leading supplier in the Canadian private-label consumer health care OTC (over-the-counter) market.

For further details, please refer to the company's news releases dated Dec. 17, 2025, and Dec. 23, 2025.